Progression

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-08
Clinical Trial Update: Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III [Phase 3]
A Phase III trial comparing bevacizumab alone versus dose-dense temozolomide followed by bevacizumab in recurrent glioblastoma is ongoing or…